Merck and Moderna's Cancer Vaccine Shows Breakthrough Results in Preventing Melanoma Recurrence
Pharmaceutical giants Merck and Moderna have announced breakthrough results from their jointly developed mRNA cancer vaccine, which demonstrates significant efficacy in preventing melanoma recurrence. This milestone marks a new era in personalized cancer treatment, offering renewed hope to millions of cancer patients worldwide.